How long will markets sustain high priced orphan drugs?

The orphan drug market was worth more than $50 billion in 2011 and turns out blockbusters at the same rate as the broader industry, according to a recent Thomson Reuters analysis. This is mostly due to the high-prices of therapies developed by the industry for rare disease patients. Even though the segment has just started to provide a great source …

Get ready to roll your sleeves up this flu season, the #NPS are recommending influenza #vaccines once again

The NPS following The Royal Australian College of General Practitioners lead, are encouraging GPs to offer influenza vaccinations to patients this winter. They are encouraging people get informed about the which vaccine is appropriate for them and realise that while so far there hasn't been any new strains of influenza identified as yet in 2012, those who were vaccinated last …